Phenotypes of Childhood Wheeze: A Trajectory Analysis

20 Nov 2026 11:15 11:30
Takao Fujisawa Speaker Japan
Childhood wheeze encompasses heterogeneous clinical courses with different implications for subsequent asthma. Birth cohorts, including Tucson, ALSPAC, and PIAMA, have established the importance of wheeze timing and persistence. However, heterogeneity among infants who already have recurrent wheeze remains less well characterized. This presentation reviews these cohort frameworks and examines how the Phenotyping of Wheezing Infants (P-WIN) study extends trajectory analysis by incorporating episode frequency. P-WIN enrolled 253 children aged 12–23 months with recurrent wheeze across 27 Japanese sites. Monthly caregiver reports supported longitudinal assessment, and 219 children completed follow-up to age three. Latent class growth analysis of annual wheeze episode counts identified four trajectories: early resolving (24.2%), low frequency with a mid-course peak (57.1%), persistent high frequency (12.8%), and late-peaking high frequency (5.9%). The two high-frequency groups comprised 18.7% of participants and experienced greater symptom burden. Household exposures, including parental smoking, showed associations with trajectory membership, although these observational findings do not establish causality. These results demonstrate clinically relevant variation in wheeze frequency and timing within an already symptomatic population. Nevertheless, trajectory membership depends on subsequent observations, and its value for baseline prediction, treatment selection, and school-age prognosis requires validation. In relation to β€œThe Evolving Immune Landscape,” P-WIN provides a clinical framework for future mechanistic investigation. Immune assessment was limited to routine IgE and eosinophil measurements, and the study did not identify immune endotypes. Repeated immune profiling could test how type 2 immunity and antiviral, epithelial, or neutrophilic pathways relate to evolving wheeze patterns. Integrating these measurements with longitudinal symptoms and school-age asthma and lung function outcomes may clarify the biological and prognostic significance of early wheeze trajectories.